Kairos Pharma Files 2024 10-K
Ticker: KAPA · Form: 10-K · Filed: Apr 15, 2025 · CIK: 1962011
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Kairos Pharma 2024 10-K filed. Full financials out.
AI Summary
Kairos Pharma, LTD. filed its 2024 10-K on April 15, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, operating in the pharmaceutical preparations sector, is based in Los Angeles, California. The filing covers the period from January 1, 2024, to December 31, 2024, and includes comparative financial data for the fiscal years 2023 and 2022.
Why It Matters
This filing provides investors and analysts with a comprehensive overview of Kairos Pharma's financial health and operational performance for the fiscal year 2024, enabling informed investment decisions.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing header and does not contain specific financial performance details or forward-looking statements that would indicate a high risk.
Key Numbers
- 2024 — Fiscal Year End (The primary year for which financial performance is reported.)
- 2023 — Prior Fiscal Year (Comparative financial data provided.)
- 2022 — Prior Fiscal Year (Comparative financial data provided.)
Key Players & Entities
- Kairos Pharma, LTD. (company) — Filer of the 10-K report
- 2024-12-31 (date) — Fiscal year end
- 2025-04-15 (date) — Filing date
- 2834 (other) — Standard Industrial Classification for Pharmaceutical Preparations
- Los Angeles, CA (location) — Business and mailing address
FAQ
What is the primary business of Kairos Pharma, LTD.?
Kairos Pharma, LTD. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code 2834.
When was the 10-K filing submitted?
The 10-K filing was submitted on April 15, 2025.
What fiscal year does this 10-K report cover?
This 10-K report covers the fiscal year ending December 31, 2024.
Where is Kairos Pharma, LTD. located?
Kairos Pharma, LTD. is located in Los Angeles, California, with its business and mailing address at 2355 Westwood Blvd. #139.
What are the SIC and SEC file numbers for Kairos Pharma, LTD.?
The Standard Industrial Classification (SIC) is 2834, and the SEC file number is 001-42275.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 15, 2025 regarding Kairos Pharma, LTD. (KAPA).